166 related articles for article (PubMed ID: 35737644)
1. Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection.
Tang Y; Luo J; Yang Y; Liu S; Zheng H; Zhan Y; Fan S; Wen Q
PLoS One; 2022; 17(6):e0265465. PubMed ID: 35737644
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
[TBL] [Abstract][Full Text] [Related]
3. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.
Yoshizawa A; Fukuoka J; Shimizu S; Shilo K; Franks TJ; Hewitt SM; Fujii T; Cordon-Cardo C; Jen J; Travis WD
Clin Cancer Res; 2010 Jan; 16(1):240-8. PubMed ID: 20008839
[TBL] [Abstract][Full Text] [Related]
5. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
6. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
Zheng J; Zhang C; Zhang Y; Pei J; Fan S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer.
Tang Y; Luo J; Zhou Y; Zang H; Yang Y; Liu S; Zheng H; Ma J; Fan S; Wen Q
BMC Cancer; 2022 May; 22(1):564. PubMed ID: 35596155
[TBL] [Abstract][Full Text] [Related]
9. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
12. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
13. RIP3/MLKL regulates necroptosis via activating 4EBP1-eIF4E pathway.
Wang S; Xu M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):979-985. PubMed ID: 37724400
[TBL] [Abstract][Full Text] [Related]
14. Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.
Ichiyanagi O; Naito S; Ito H; Kabasawa T; Narisawa T; Kanno H; Kurota Y; Kurokawa M; Fukuhara H; Sakurai T; Nishida H; Kato T; Yamakawa M; Tsuchiya N
Clin Genitourin Cancer; 2018 Oct; 16(5):e1029-e1058. PubMed ID: 30297141
[TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer.
Liu S; Wang W; Ning Y; Zheng H; Zhan Y; Wang H; Yang Y; Luo J; Wen Q; Zang H; Peng J; Ma J; Fan S
Cell Death Dis; 2022 Feb; 13(2):129. PubMed ID: 35136028
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
[TBL] [Abstract][Full Text] [Related]
17. [Expression and its clinical significance of eIF4E in non-small cell lung cancer].
ZHANG B; ZHU C; CHEN B; ZHANG X; YE M; LIN A
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1132-5. PubMed ID: 21159249
[TBL] [Abstract][Full Text] [Related]
18. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
Li Y; Fan S; Koo J; Yue P; Chen ZG; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Cancer Biol Ther; 2012 Mar; 13(5):272-80. PubMed ID: 22236867
[TBL] [Abstract][Full Text] [Related]
20. [Expression of hUTP14a in non-small cell lung cancer].
Zhang CF; Liu Y; Lu M; DU XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]